• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Nat Commun . SARS-CoV-2 spike-protein D614G mutation increases virion spike density and infectivity

tetano

Editor, Senior Moderator
Nat Commun


. 2020 Nov 26;11(1):6013.
doi: 10.1038/s41467-020-19808-4.
SARS-CoV-2 spike-protein D614G mutation increases virion spike density and infectivity


Lizhou Zhang[SUP] 1 [/SUP], Cody B Jackson[SUP] 1 [/SUP], Huihui Mou[SUP] 1 [/SUP], Amrita Ojha[SUP] 1 [/SUP], Haiyong Peng[SUP] 1 [/SUP], Brian D Quinlan[SUP] 1 [/SUP], Erumbi S Rangarajan[SUP] 2 [/SUP], Andi Pan[SUP] 1 [/SUP], Abigail Vanderheiden[SUP] 3 4 5 6 [/SUP], Mehul S Suthar[SUP] 3 4 5 6 [/SUP], Wenhui Li[SUP] 7 [/SUP], Tina Izard[SUP] 2 [/SUP], Christoph Rader[SUP] 1 [/SUP], Michael Farzan[SUP] 8 [/SUP], Hyeryun Choe[SUP] 9 [/SUP]



Affiliations

Abstract

SARS-CoV-2 variants with spike (S)-protein D614G mutations now predominate globally. We therefore compare the properties of the mutated S protein (S[SUP]G614[/SUP]) with the original (S[SUP]D614[/SUP]). We report here pseudoviruses carrying S[SUP]G614[/SUP] enter ACE2-expressing cells more efficiently than those with S[SUP]D614[/SUP]. This increased entry correlates with less S1-domain shedding and higher S-protein incorporation into the virion. Similar results are obtained with virus-like particles produced with SARS-CoV-2 M, N, E, and S proteins. However, D614G does not alter S-protein binding to ACE2 or neutralization sensitivity of pseudoviruses. Thus, D614G may increase infectivity by assembling more functional S protein into the virion.
 
Back
Top Bottom